Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D3GF
|
|||
Former ID |
DNC006883
|
|||
Drug Name |
1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea
|
|||
Synonyms |
CHEMBL386820; 1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea; SCHEMBL5144023; BDBM100356; BDBM50191894; US8501783, 1160
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H35N3O
|
|||
Canonical SMILES |
CCCCN1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
|
|||
InChI |
1S/C20H35N3O/c1-2-3-6-23-7-4-18(5-8-23)21-19(24)22-20-12-15-9-16(13-20)11-17(10-15)14-20/h15-18H,2-14H2,1H3,(H2,21,22,24)
|
|||
InChIKey |
FTNAVCVMGWLLJE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Peroxisome | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Metapathway biotransformation | |||
Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.